Oligodendrocyte-type 2 astrocyte-derived trophic factors increase survival of developing dopamine neurons through the inhibition of apoptotic cell death

Journal of Comparative Neurology

Volumn 426, Issue 1, 2000, Pages 143-153

  Yilmazer Hanke, Deniz M ^a   Hudson, Robyn ^b,c   Distel, Hans ^b  

^a OTTO VON GUERICKE UNIVERSITY   (Germany)

^b UNIVERSITY OF MUNICH   (Germany)

^c UNIVERSIDAD NACIONAL AUTÓNOMA DE MÉXICO   (Mexico)

Author keywords

Apoptosis; Mesencephalon; O2A progenitor; Parkinson's disease; Striatum; Substantia nigra; Transplantation

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR; DOPAMINE; GLIAL CELL LINE DERIVED NEUROTROPHIC FACTOR; LACTATE DEHYDROGENASE; NEUROTROPHIC FACTOR;

ANIMAL CELL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CELL SURVIVAL; CELL TRANSPLANTATION; CONTROLLED STUDY; CORPUS STRIATUM; DOPAMINERGIC NERVE CELL; EMBRYO; FEMALE; IMMUNOHISTOCHEMISTRY; MESENCEPHALON; NICK END LABELING; NONHUMAN; OLIGODENDROGLIA; PARKINSON DISEASE; PHENOTYPE; PRIORITY JOURNAL; RAT; STEM CELL; SUBSTANTIA NIGRA;

ANIMALS; APOPTOSIS; ASTROCYTES; BRAIN TISSUE TRANSPLANTATION; CELL SURVIVAL; CELLS, CULTURED; CULTURE MEDIA, CONDITIONED; DOPAMINE; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; FETUS; FIBROBLAST GROWTH FACTOR 2; NECROSIS; NERVE GROWTH FACTORS; NEURONS; OLIGODENDROGLIA; PARKINSON DISEASE; PHENOTYPE; PLATELET-DERIVED GROWTH FACTOR; PREGNANCY; RATS; RATS, INBRED F344; STEM CELLS; TYROSINE 3-MONOOXYGENASE;

EID: 0034626626     PISSN: 00219967     EISSN: None     Source Type: Journal    
DOI: 10.1002/1096-9861(20001009)426:1<143::AID-CNE10>3.0.CO;2-8     Document Type: Article

References (56)

1. Functional re-innervation of the neostriatum in the adult rat by use of intraparenchymal grafting of dissociated ceil suspensions from the substantia nigra
2. Cooperation between two growth factors promotes extended self-renewal and inhibits differentiation of oligodendrocyte-type-2 astrocyte (O2A) progenitor cells
3. Neural apoptosis
4. Optimized survival of hippocampal neurons in B27-supplemented neurobasal, a new serum-free medium combination
5. Neurobasal medium/B27 supplement: A new serum-free medium combination for survival of neurons
6. Monitoring of cell viability in suspensions of embryonic CNS tissue and its use as a criterion for intercerebral graft survival
7. Survival and function of dissociated dopamine neurons grafted at different developmental stages or after being cultured in vitro
8. Treatment of Parkinson's disease
9. Striatal extracts from patients with Parkinson's disease promote dopamine neuron growth in mesencephalic cultures
10. Loss of striatal DA innervation increases striatal trophic activity directed at DA neurons in culture
11. Ontogeny and distribution of glial cell line-derived neurotrophic factor (GDNF) mRNA in rat
12. GDNF reduces apoptosis in dopaminergic neurons in vitro
13. Therapeutic potential of nerve growth factors in Parkinson's disease
14. Co-transplantation of fetal lateral ganglionic eminence and ventral mesencephalon can augment function and development of intrastriatal transplants
15. Development and survival of neurons in dissociated fetal mesencephalic serum-free cell cultures: I. Effects of cell density and of an adult mammalian striatal-derived neuronotrophic factor (SDNF)
16. Temporal analysis of events associated with programmed cell death (apoptosis) of sympathetic neurons deprived of nerve growth factor
17. Direct interaction with target-derived glia enhances survival but not differentiation of human fetal mesencephalic dopaminergic neurons
18. Changing responsiveness of developing midbrain dopaminergic neurons for extracellular growth factors
19. Is levodopa toxic?
20. Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation
21. Truncated IGF-1 exerts trophic effects on fetal brain tissue grafts
22. Acidic and basic fibroblast growth factors augment growth of fetal brain tissue grafts
23. Enhanced dopamine cell survival in reaggregates containing telencephalic targets
24. Naturally occurring cell death during postnatal development of the substantia nigra of the rat
25. Conditioned medium from aged monkey fibroblasts stably expressing GDNF and BDNF improves survival of embryonic dopamine neurons in vitro
26. Neuropathological evidence of graft survival and striatal reinnervation after the transplantation of fetal mesencephalic tissue in a patient with Parkinson's disease
27. Functional fetal nigral grafts in a patient with Parkinson's disease: Chemoanatomic, ultrastructural, and metabolic studies
28. Prenatal ontogeny of the epidermal growth factor receptor and its ligand, transforming growth factor alpha, in the rat brain
29. Apoptosis in substantia nigra following developmental striatal exitotoxic injury
30. Programmed cell death in developing grafts of fetal substantia nigra
31. Early developmental destruction of terminals in the striatal target induces apoptosis in dopamine neurons of the substantia nigra
32. Enhanced survival of cultured dopamine neurons by treatment with soluble extracts from chemically deafferentiated striatum of adult rat brain
33. Cellular expression of GDNF mRNA suggests multiple functions inside and outside the nervous system
34. Fetal nigral transplantation as a therapy for Parkinson's disease
35. The time course of developmental cell death in phenotypically defined dopaminergic neurons of the substantia nigra
36. Increased proportion of acetylcholinesterase-rich zones and improved morphological integration in host striatum of fetal grafts derived from lateral but not medial ganglionic eminence
37. Programmed cell death and the control of cell survival: Lessons from the nervous system
38. Glial cell line-derived neurotrophic factor increases survival, growth and function of intrastriatal fetal nigral dopaminergic grafts
39. Regional and cell-specific expression of GDNF in rat brain
40. Caspase inhibition reduces apoptosis and increases survival of nigral transplants
41. Expression of neurotrophins by midbrain dopaminergic neurons
42. Co-grafted embryonic striatum increases the survival of grafted embryonic dopamine neurons
43. Time course of apoptotic cell death in mesencephalic suspension grafts: Early trophic influence of O2A progenitor-enriched striatal co-grafts
44. Basic fibroblast growth factor enhances survival and sprouting of fetal dopaminergic cells implanted in the denervated rat striatum
45. Mechanisms and genes of cellular suicide
46. Glial cell line-derived neurotrophic factor is expressed in the developing but not adult striatum and stimulates developing dopamine neurons in vivo
47. Basic fibroblast growth factor increases dopaminergic graft survival and function in a rat model of Parkinson's disease
48. Mesencephalic type 1 astrocytes rescue dopaminergic neurons from death induced by serum deprivation
49. Oligodendrocyte-type-2 astrocyte (O2A) progenitors increase the survival of rat mesencephalic, dopaminergic neurons from death induced by serum deprivation
50. Astrocyte-dependent and -independent phases of the development and survival of rat embryonic day 14 mesencephalic, dopaminergic neurons in culture
51. Standardized methods to bioassay neurotrophic factors for dopaminergic neurons
52. Apoptosis and secondary necrosis of lymphocytes in culture
53. Neurturin and glial cell line-derived neurotrophic factor receptor-beta (GDNFR-beta), novel proteins related to GDNF and GDNF-alpha with specific cellular patterns of expression suggesting roles in the developing and adult nervous system and in peripheral organs
54. Localization of cells synthesizing transforming growth factor-alpha mRNA in the mouse brain
55. Growth factors rescue embryonic dopamine neurons from programmed cell death
56. Growth factors improve immediate survival of embryonic dopamine neurons after transplantation into rats